Aoxing Pharmaceutical (AXN) Widens Q3 Loss to 6c/Share

Aoxing Pharmaceutical Co., Inc. (NYSE: AXN) reported Q3 EPS of ($0.06), versus ($0.01) reported last year. Revenue for the quarter came in at $1.81 million, versus $1.63 million reported last year.

For earnings history and earnings-related data on Aoxing Pharmaceutical Co., Inc. (AXN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BofA says momentum style supported by earnings revisions
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand